Proteomic profiling identifies distinct protein patterns in acute myelogenous leukemia CD34+CD38- stem-like cells

Area of Science:

• Hematology
• Cancer Biology
• Proteomics

Background:

• Acute myeloid leukemia (AML) is driven by leukemic stem-like cells (LSC).
• Understanding LSC biology is critical for deciphering AML pathogenesis.
• Key differences between LSC, normal stem cells (HSC), and common myeloid progenitors (CMP) remain incompletely understood.

Purpose of the Study:

• To investigate and compare protein expression patterns in LSC versus other AML cell populations.
• To identify distinct protein signatures of LSC.

Main Methods:

• Purification of five distinct cell fractions from AML samples: Bulk, CD34-, CD34+(CMP), CD34+CD38+, and CD34+CD38-(LSC).
• Quantitative analysis of 121 proteins using Reverse Phase Protein Arrays (RPPA).
• Statistical analysis including principal component and protein signaling network analysis.

Main Results:

• LSC exhibited significantly different protein expression compared to Bulk and CD34+ AML cells (93/121 and 88/121 proteins, respectively).
• 54 proteins showed significant differential expression in LSC (31 higher, 23 lower) compared to Bulk or CD34+ cells.
• Protein expression profiles in LSC and CD34+ cells were markedly distinct from normal CD34+ cells.
• Principal component and network analyses confirmed LSC distinctness.

Conclusions:

• Protein expression and activation patterns in LSC are markedly different from other AML blast populations.
• Identified potential targetable proteins and signaling pathways within LSC, including PU.1, P27, Mcl1, HIF1α, cMET, P53, Yap, and phospho-Stats.
• Findings suggest that LSC-specific studies are essential for advancing AML research and therapeutic strategies.